Last reviewed · How we verify
NCT06383065
Respiratory Physiotherapy in Type 2 Diabetes and Bariatric Surgery
NA trial testing IMT Group in Type 2 Diabetes in 40 participants. Completed in 30 January 2022.
30 April 2021
Quick facts
| Lead sponsor | Near East University, Turkey |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 February 2020 |
| Primary completion | 30 April 2021 |
| Estimated completion | 30 January 2022 |
| Sites | 1 location across Cyprus |
Drugs / interventions tested
- IMT Group
Conditions studied
- Type 2 Diabetes — all drugs for Type 2 Diabetes →
- Bariatric Surgery Candidate — all drugs for Bariatric Surgery Candidate →
Sponsor
Near East University, Turkey
Who can join
Adults 25 to 65, any sex, with Type 2 Diabetes or Bariatric Surgery Candidate. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to investigate the early effects of Inspiratory Muscle Training (IMT) applied before and after bariatric surgery on respiratory function, respiratory muscle strength and functional capacity in individuals with type 2 diabetes. The study will be conducted with 40 individuals with type 2 diabetes aged between 25-65. Individuals will be randomly assigned to the IMT (trained at 30% of maximum inspiratory pressure with an IMT threshold device) and control group. As measurement parameters, a 6-minute walk test for functional capacity, a spirometry test for respiratory function, and a portable device (Cosmed Pony FX Desktop Spirometer, USA) will be used for respiratory muscle strength. Hand grip strength will be measured with a Baseline dynamometer. All measurements will be repeated on the first day before surgery and on the fourth day before discharge after surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06383065
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Type 2 Diabetes
Currently open trials in the same condition.
- NCT07053319 — SGLT2i, Pioglitazone, and Ketone Production in T2D · Phase 1 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
- NCT07254689 — The Food for Health Study · NA · recruiting
- NCT07558863 — Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes · Phase 4 · recruiting
Other Near East University, Turkey trials
Trials by the same sponsor.
- NCT07135921 — Sleep Hygiene Education in Individuals With Cardiovascular Disease: Effects on Sleep Quality and Disease Management · NA · not yet recruiting
- NCT07500675 — The Effect of an Escape Room Simulation on Nursing Students' Educational Leadership Skills: An Experimental Study · NA · enrolling by invitation
- NCT07347652 — This Research Proposal Focuses on Evaluating the Effectiveness of a Nursing Care Protocol in Preventing Deep Vein Thromb · NA · active not recruiting
- NCT06754683 — The Effect of Self-Compassion Interventions on Nursing Students' Stress, Resilience, and Psychological Well-Being · NA · completed
- NCT07470632 — Effect of Twin Hearts Meditation and Mandala Coloring on Exam Anxiety in Nursing Students · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06383065 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Near East University, Turkey
- Last refreshed: 25 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06383065.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing